For decades, the medical community has grappled with a persistent trend: breast cancers diagnosed in women shortly...
Clinical Oncology Education
The U.S. Food and Drug Administration (FDA) has officially approved isatuximab-irfc for subcutaneous injection, marking a significant...
The landscape of prostate cancer treatment is undergoing a seismic shift, particularly for patients facing the daunting...
In a medical landscape often defined by incremental progress, a decade-long study from the Abramson Cancer Center...
In a landmark advancement for oncology, researchers have unveiled results from a first-in-human phase I clinical trial...
Introduction: A Paradigm Shift in Neurointerventional Oncology The battle against malignant brain tumors has long been hindered...
In a significant development for oncology care, a Phase II clinical trial has unveiled a potential breakthrough...
For decades, the mention of "palliative care" in an oncology ward has been met with a quiet,...
In the landscape of oncology, clear cell renal cell carcinoma (ccRCC) has long been regarded as a...
The landscape of breast cancer treatment in the European Union is undergoing a significant transformation. In a...
